tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INSM Stock Latest News

Roth Capital biotech analyst holds an analyst/industry conerence call
The FlyRoth Capital biotech analyst holds an analyst/industry conerence call
6d ago
ELMD
INSM
Insmed (INSM) Executives Engage in Coordinated Stock Sale
PremiumMarket News
Insmed (INSM) Executives Engage in Coordinated Stock Sale
12d ago
INSM
Insmed’s ENCORE Trial Reaches Key Milestone in MAC Lung Infection
PremiumCompany Announcements
Insmed’s ENCORE Trial Reaches Key Milestone in MAC Lung Infection
14d ago
INSM
Insmed call volume above normal and directionally bullish
PremiumThe Fly
Insmed call volume above normal and directionally bullish
17d ago
INSM
Psychedelic: Analyst raises Compass, Definium, GH Research price targets
PremiumThe Fly
Psychedelic: Analyst raises Compass, Definium, GH Research price targets
19d ago
PBM
CMPS
Definium Therapeutics appoints Roger Adsett to board of directors
PremiumThe FlyDefinium Therapeutics appoints Roger Adsett to board of directors
19d ago
DFTX
INSM
Insmed initiated with an Overweight at Barclays
Premium
The Fly
Insmed initiated with an Overweight at Barclays
20d ago
INSM
Insmed initiated with a Buy at Roth Capital
Premium
The Fly
Insmed initiated with a Buy at Roth Capital
25d ago
INSM
Insmed price target raised to $200 from $197 at RBC Capital
PremiumThe Fly
Insmed price target raised to $200 from $197 at RBC Capital
27d ago
INSM
Insmed: Strong Brensocatib Launch but Pipeline and Payer Uncertainties Keep Risk‑Reward Balanced at Hold
PremiumRatings
Insmed: Strong Brensocatib Launch but Pipeline and Payer Uncertainties Keep Risk‑Reward Balanced at Hold
1M ago
INSM
Unusually active option classes on open January 9th
PremiumThe Fly
Unusually active option classes on open January 9th
1M ago
FNF
LDI
Insmed: Strong Brinsupri Launch, Solid Arikayce Performance, and 2026 Catalysts Underpin Buy Rating
PremiumRatings
Insmed: Strong Brinsupri Launch, Solid Arikayce Performance, and 2026 Catalysts Underpin Buy Rating
1M ago
INSM
Insmed Announces Strong 2025 Results and Pipeline Progress
PremiumCompany AnnouncementsInsmed Announces Strong 2025 Results and Pipeline Progress
1M ago
8K
INSM
Insmed announces anticipated milestones for 2026
Premium
The Fly
Insmed announces anticipated milestones for 2026
1M ago
INSM
Insmed sees FY25 revenue $606.4M, consensus $522.03M
Premium
The Fly
Insmed sees FY25 revenue $606.4M, consensus $522.03M
1M ago
INSM
Insmed sees FY26 global Arikayce revenue $450M-$470M
PremiumThe Fly
Insmed sees FY26 global Arikayce revenue $450M-$470M
1M ago
INSM
Insmed sees FY25 Arikayce revenue $433.8M
PremiumThe Fly
Insmed sees FY25 Arikayce revenue $433.8M
1M ago
INSM
Insmed price target lowered to $157 from $158 at Morgan Stanley
PremiumThe Fly
Insmed price target lowered to $157 from $158 at Morgan Stanley
1M ago
INSM
Insmed price target lowered to $215 from $223 at UBS
PremiumThe Fly
Insmed price target lowered to $215 from $223 at UBS
1M ago
INSM
Mereo Biopharma Stock (MREO) Collapses over 90% after Failed Trials
PremiumMarket NewsMereo Biopharma Stock (MREO) Collapses over 90% after Failed Trials
2M ago
AZN
INSM
Insmed assumed with a Buy at Truist
Premium
The Fly
Insmed assumed with a Buy at Truist
2M ago
INSM
Insmed: Brinsupri-Led Growth, Pipeline Optionality, and Discounted Valuation Underpin Buy Rating
Premium
Ratings
Insmed: Brinsupri-Led Growth, Pipeline Optionality, and Discounted Valuation Underpin Buy Rating
2M ago
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >